Assessing the alignment of obstructive hypertrophic cardiomyopathy pharmacological treatments with ESC guidelines in Germany

Back

ESC Premium Access

Assessing the alignment of obstructive hypertrophic cardiomyopathy pharmacological treatments with ESC guidelines in Germany

Session: Hypertrophic obstructive cardiomyopathy (HOCM): clearing the roadblock

Topic: Hypertrophic Cardiomyopathy

Speaker: Associate Professor F. Sedaghat-Hamedani (Heidelberg, DE)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Associate Professor Farbod Sedaghat-Hamedani

University Hospital Heidelberg, Heidelberg (Germany)

1 presentation

0 follower

8 more presentations in this session

Epidemiology and prognosis of obstructive and non-obstructive hypertrophic cardiomyopathy in Finland: a nationwide cohort study

Speaker: Assistant Professor M. Laine (Helsinki, FI)

Non-invasive assessment of left ventricular hemodynamic forces in hypertrophic cardiomyopathy

Speaker: Doctor G. Panichella (Florence, IT)

Functional capacity by cardiopulmonary exercise testing is not related to health status in obstructive hypertrophic cardiomyopathy

Speaker: Doctor L. Bjerregaard (Aarhus, DK)

Hemodynamic effects of right and biventricular pacing during exercise in hypertrophic obstructive cardiomyopathy

Speaker: Doctor T. Ahmed (Oslo, NO)

Evaluation of clinical need, effectiveness, and safety of the first myosin inhibitor mavacamten in real world patients

Speaker: Doctor L. Seuthe (Cologne, DE)

Access the full session

Hypertrophic obstructive cardiomyopathy (HOCM): clearing the roadblock

Speakers: Associate Professor F. Sedaghat-Hamedani, Assistant Professor M. Laine, Doctor G. Panichella, Doctor L. Bjerregaard, Doctor T. Ahmed...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources